USSTOCK.TODAY
Pre-Market
Log in Sign up

Pfizer and Alphabet: Attractive Undervalued Investment Opportunities

The Motley Fool +1 · ·by G4L

PFE Pfizer Inc
$28.83 -2.11%
View chart & analysis →
  1. 1Pfizer recorded revenue slightly exceeding $100 billion in 2022.
  2. 2Pfizer plans to launch at least 8 innovative blockbuster cancer treatments by 2030.
  3. 3Alphabet's third-quarter revenue reached $127.6 billion, an increase of approximately 25% year-over-year.

So what's the key point?

Pfizer generated large revenues and Alphabet's revenue grew by 25%. Both companies represent attractive investment opportunities with expected future growth.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

Eli Lilly secures first-mover advantage with opforglipron approval in China Stocktwits +2 · yesterdayChina's drug regulator approves Eli Lilly's obesity treatment orforglipron Investing.com +2 · yesterdayPfizer conducts late-stage clinical trials to compete in GLP-1 weight loss market The Motley Fool +1 · 5d ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news